| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/09/1996 | US5505945 Method and compositions for the direct concentrated delivery of passive immunity |
| 04/09/1996 | US5505941 Inoculating host with synthetic genetic engineered pathogen |
| 04/09/1996 | US5505931 Isothiocyanate containing anhydride compounds; useful for controlled release of nucleophilic group of diagnostic or therapeutic agent |
| 04/07/1996 | CA2159958A1 New toxoplasma gondii antigens |
| 04/07/1996 | CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta. |
| 04/04/1996 | WO1996010086A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | WO1996010081A1 Vaccine composition comprising recombinant bcg expressing gp63 fusion protein |
| 04/04/1996 | WO1996010041A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 04/04/1996 | WO1996010039A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009805A2 Chitosan induced immunopotentiation |
| 04/04/1996 | WO1996005315A3 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 04/04/1996 | WO1996004933A3 Cck antibodies used to improve feed efficiency |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | DE4434551A1 Peptide aus der Sequenz des hPTH (1-37) Peptides from the sequence of hPTH (1-37) |
| 04/04/1996 | CA2200973A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | CA2200550A1 Chitosan induced immunopotentiation |
| 04/04/1996 | CA2200338A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704533A1 An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus |
| 04/03/1996 | EP0704529A2 Vaccine against rabbit hemorrhagic disease virus |
| 04/03/1996 | EP0704528A2 Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing them |
| 04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |
| 04/03/1996 | EP0704056A1 Leukocyte adhesion assay |
| 04/03/1996 | EP0703989A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
| 04/03/1996 | EP0703981A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
| 04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 04/03/1996 | EP0703925A1 Production of antibody fragments |
| 04/03/1996 | EP0703922A1 Immunoglobulin g concentrate for therapeutical use and method for producing same |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703789A1 Vaccine containing a serine protease |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0494247B1 Reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | EP0328589B1 Tetra-aza macrocycles and metal complexes thereof |
| 04/03/1996 | CN1119854A Acylfulvene analogues as antitumor agents |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/02/1996 | US5504005 Recombinant mycobacterial vaccine |
| 04/02/1996 | US5503992 DNA encoding the 15kD outer membrane protein of Haemophilus influenzae |
| 04/02/1996 | US5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 04/02/1996 | US5503976 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and diagnostic typing processes and products related thereto |
| 04/02/1996 | US5503841 Administering to enhance immune response to vaccine |
| 04/02/1996 | US5503834 Dna coding for measles virus hemagglutinin glycoprotein or fusion glycoprotein; protecting dogs from canine distemper |
| 04/02/1996 | US5503830 Polyamine cationic polymers |
| 04/02/1996 | US5503829 Recombinant adenylate cyclase of bordetella comprising at least one heterologous epitope inserted between amino acids 235 and 236 |
| 03/28/1996 | WO1996009395A2 Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases |
| 03/28/1996 | WO1996009391A2 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
| 03/28/1996 | WO1996009380A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009321A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009043A1 Methods for the treatment of inflammatory joint disease |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | WO1996004301A3 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
| 03/27/1996 | EP0703295A1 Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein |
| 03/27/1996 | EP0703294A1 Marek's disease virus vaccine |
| 03/27/1996 | EP0702960A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
| 03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702722A1 Plasmids suitable for gene therapy |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702693A1 Tandem synthetic hiv-1 peptides |
| 03/27/1996 | EP0702692A1 Regulation of antigen presentation |
| 03/27/1996 | EP0702689A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| 03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/27/1996 | EP0702565A1 CATALASE-BASED ANTI-$i(HELICOBACTER PYLORI) IMMUNISING COMPOSITION |
| 03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
| 03/27/1996 | EP0702563A1 Compositions and methods for treating cancer and hyperproliferative disorders |
| 03/27/1996 | EP0702516A1 Genetic immunization with cationic lipids |
| 03/27/1996 | EP0549617B1 Improved vaccine compositions |
| 03/27/1996 | EP0495053B1 New linker for bioactive agents |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/27/1996 | CN1119458A Nucleic acid pharmaceuticals |
| 03/27/1996 | CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 03/27/1996 | CN1119414A Stabilised pharmaceutical compositions and methods for preparing same |
| 03/27/1996 | CA2159044A1 Method of quantitating nucleic acids |
| 03/26/1996 | US5502168 Polypeptides for malaria vaccines |
| 03/26/1996 | US5502167 CDR grafted humanised chimeric T-cell antibodies |
| 03/26/1996 | US5502039 Cystic fibrosis |
| 03/26/1996 | US5502037 Antitumor agents for procytotoxic drugs |
| 03/26/1996 | US5502022 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
| 03/26/1996 | US5501969 Bone disorders, antitumor |
| 03/26/1996 | CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues |
| 03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008557A1 Human inositol monophosphatase h1 |
| 03/21/1996 | WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 03/21/1996 | WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 03/21/1996 | WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
| 03/21/1996 | WO1996008273A1 Pharmaceutical compositions containing d2o |
| 03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 03/21/1996 | WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 03/21/1996 | WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | WO1996008231A1 Control of hair growth |